28-Jul-2005 - MilliporeSigma

Sigma-Genosys Enters Agreement With Novatia

Sigma-Genosys, a division of Sigma-Aldrich has incorporated into its quality control (QC) lab an LC-MS system from Novatia. The system improves the molecular weight determination of larger synthetic oligonucleotides (>50 bases) as well as synthetic peptides. Novatia specializes in developing an integrated system encompassing hardware, software, method development and automated data analysis.

Traditionally, larger synthetic oligonucleotides are analyzed by capillary electrophoresis and by PAGE analysis. When molecular weight information is needed, MALDI-TOF mass analysis is carried out. Traditional MALDI-TOF MS analysis while rapid (<5 seconds per sample) and relatively simple, provides inadequate mass spectra data if any, for larger oligonucleotides. This is due primarily to poor ionization of the large oligonucleotides.

With the integrated Novatia LC-MS system, Sigma-Genosys is able to obtain high quality mass analysis of larger oligonucleotides. Traditional LC-MS techniques can be time consuming and not amenable to high throughput analysis.

The LC-MS system by Novatia along with their methods and their automated post-analysis software provides Sigma-Genosys with a high throughput (one sample per minute) LC-MS technique for the analyses of larger oligonucleotides. The well-integrated instrument and protocols developed by Novatia reduced the IOQ (installation/operating qualification) time to days from the weeks normally associated with high-technology analytical systems.

The Novatia system also provides Sigma-Genosys with the ability to obtain higher quality mass spectra data in a high throughput format. The improved resolution obtained by LC-MS provides more accurate molecular weight of the larger oligonucleotides. This allows detection of base substitutions as well as being able to determine the presence and identification of potential contaminates and base deletions.

More about Sigma-Aldrich
  • News

    Merck Completes Sigma-Aldrich Acquisition

    Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more

    Merck Set to Complete Sigma-Aldrich Acquisition

    Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich. The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the dive ... more

    Merck announces Sigma-Aldrich business sale to Honeywell

    Merck announced that Sigma-Aldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisiti ... more

  • Companies

    Sigma-Aldrich Chemie GmbH

    more

    Sigma-Aldrich Corp.

    Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

    Sigma-Aldrich Química, S.A. de C.V.

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

More about Sigma-Genosys